SCHEMBL7323880

SCHEMBL7323880

COC(=O)c1cccc(NC(=O)c2ccc(C(F)(F)F)cc2)c1N

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 5/20 0.59
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
TSHR P16473 1/20 0.56
CYP2C19 P33261 1/20 0.56
RXFP1 Q9HBX9 5/20 0.53
ELANE P08246 1/20 0.50
PRTN3 P24158 1/20 0.50
CFTR P13569 1/20 0.50
APOBEC3A P31941 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49
HPGD P15428 1/20 0.48
MAPK10 P53779 1/20 0.48
KDM4E B2RXH2 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
PARP1 P09874 1/20 0.47
HDAC1 Q13547 1/20 0.47
PPARG P37231 1/20 0.47
PPARD Q03181 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7321066 0.89 PTGS1 (0.64) PTGS1RXFP1HTTKMT2A
SCHEMBL7318242 0.87 TSHR (0.58) CYP1A2CYP2D6TSHRCYP2C19ELANE
SCHEMBL3920156 0.86 TSHR (0.58) PTGS1CYP1A2CYP2D6TSHRCYP2C19
SCHEMBL7519755 0.85 PTGS1 (0.63) PTGS1RXFP1KMT2APARP1PPARG
SCHEMBL7311425 0.85 TSHR (0.59) CYP1A2CYP2D6TSHRCYP2C19ELANE
SCHEMBL7315643 0.84 HDAC1 (0.64) CYP1A2CYP2D6TSHRCYP2C19RXFP1
SCHEMBL7322634 0.83 PTGS1 (0.55) PTGS1CYP1A2CYP2D6TSHRCYP2C19
SCHEMBL505634 0.83 PDCD1 (0.60) CYP1A2CYP2D6TSHRCYP2C19ELANE
SCHEMBL7318284 0.81 RXFP1 (0.57) CYP1A2CYP2D6TSHRCYP2C19RXFP1
SCHEMBL18255503 0.80 RAB9A (0.64) CYP1A2CYP2D6TSHRCYP2C19ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841924-B1 BENZIMIDAZOLE COMPOUNDS UNIV NEWCASTLE VENTURES LTD (GB) 2002-10-02 EP disclosed
US-6310082-B1 PHARMACEUTICAL COMPOSITION COMPRISING EFFECTIVE POLY(ADP-RIBOSE)POLYMERASE ENZYME INHIBITING AMOUNT OF BENZIMIDAZOLE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT AND/OR PRO-DRUG FORM THEREOF, WITH ACCEPTABLE CARRIER NEWCASTLE UNIVERSITY VENTURES LIMITED (GB) 2001-10-30 US disclosed
US-6100283-A PRODRUG PHOSPHATE DERIVATIVE FOR POLY (ADP-RIBOSE) POLYMERASE ENZYME INHIBITOR FOR ADMINISTERING IN CONJUNCTION WITH ANTITUMOR DRUG OR RADIOTHERAPY NEWCASTLE UNIVERSITY VENTURES LIMITED (GB) 2000-08-08 US disclosed
EP-0841924-A1 BENZIMIDAZOLE COMPOUNDS NEWCASTLE UNIVERSITY VENTURES LIMITED (GB) 1998-05-20 EP disclosed
WO-1997004771-A1 BENZIMIDAZOLE COMPOUNDS NEWCASTLE UNIVERSITY VENTURES LIMITED (GB) 1997-02-13 WO disclosed